Institutional investors purchased a net $864.8 thousand shares of INSM during the quarter ended December 2012 and now own 38.85% of the total shares outstanding. This is a greater percentage than is typical for companies in the Biotechnology industry and highlights that the smart money sees this stock as an important holding.
| Individual stakeholders | 7.89% |
| Other institutional | 26.55% |
| Mutual fund holders | 12.31% |